HMGCR and familial hypercholesterolemia: Considering their powerful inhibition of HMGCR activity and, in turn, cholesterol biosynthesis, natural and synthetic statins successfully entered clinical practice, becoming the gold standard to reduce hypercholesterolemia and the risk of CVD [71,72].